ArticleOncotarget2016

RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.

Lucas Goedert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.